Soft drink increase cancer risk

Regular consumption of soft drinks can increase the risk of developing pancreatic cancer and liver disease. A Singapore Chinese health study on more than 60 thousand people found that individuals who consumed two or more soft drinks per week had an 87 percent increased risk for pancreatic cancer, compared with those who did not.

However, the study did not find a link between the consumption of juice and an increased risk for pancreatic cancer. The high levels of sugar in soft drinks can increase levels of insulin in the body, leading to pancreatic cancer cell growth, the researchers explain. The findings were reported in the Cancer Epidemiology, Biomarkers & Prevention.

Another research reported in the Journal of Hepatology revealed that too much sweetened soda and fruit joice may cause long-term liver damage.

Researchers discovered that about 80 percent of the people in the study, who developed fatty liver, drank more than half a litre( about two cups) of sweetened soft drinks every day. The ingradient in the drinks that causes the damage is a fruit sugar called fructose, which is highly abdorbable in the liver.

Fructose increases the risk of fatty liver, which can lead to cirrhosis of the liver and liver cancer, said a researcher.

This article is published in latest edition of INSIGHT- the consumer magazine.
www.cercindia.org

Thanks.
www.mindbodysoul.in

http://mGinger.com/index.jsp?inviteId=1339125

Drug Sibutramine

Anti-obesity Sibutramine Drug can be risky

The European Medicines Evaluation Agency (EMEA) - the European Union equeivalent of the US food and Drug Administration (FDA)- has warned against the use of Sibutramine, recommending that doctors no longer prescribe and pharmacists no longer dispense the drug.

The FDA also has suggested that sibutramine be avoided in patients with a history of coronary artery disease (heart disease), congestive heart failure, arrhythmias, of stroke, and that the manufacturers add a new contradiction to the drug lebel to this effect.

Though no adverse effects have been reported in India, according to media reports, now the Drug Controller General of India (DCGI) has decided to take the matter to an expert group.

Some commonly brands of Sibutramine drugs in India are: Sibutrex, Sibutrim, slenfig etc.

This article is published in the Consumer magazine Insight- june 2010.

Thanks.

www.mindbodysoul.in

http://mGinger.com/index.jsp?inviteId=1339125